5
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: Dependency on age, sex and glomerular filtration

, , , &
Pages 673-678 | Received 04 Nov 1983, Accepted 04 Jun 1984, Published online: 08 Jul 2009

References

  • Caniggia A., Vattimo A. Kinetics of 99m‐technetium‐tin methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif. Tissue Int. 1980; 30: 5
  • Christiansen C., Christensen M. S., Larsen N. ‐E., Transbød I. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose‐response relationship in early postmenopausal women. J. Clin. Endocrinol. Metab. 1982; 55: 1124
  • Christiansen C., Christensen M. S., Roedbro P., Hagen C., Transbøl I. Effect of 1.25‐dihydroxy‐vitamin D3 in itself and combined with hormone treatment in preventing postmenopausal osteoporosis. Eur. J. Clin. Invest. 1981; 11: 305
  • Crilly R. G., Jones M. M., Horsman A., Nordin B. E.C. Rise in plasma alkaline phosphatase at the menopause. Clin. Sci. 1980; 58: 341
  • Fogelman I., Bessent R. G. Age‐related alterations in skeletal metabolism—24‐hr whole body retention of diphosphonate in 250 normal subjects: concise communication. J. Nucl. Med. 1982; 23: 296
  • Fogelman I., Bessent R. G., Beastall G., Boyle I. T. Estimation of skeletal involvement in primary hyperparathyroidism. Ann. Intern. Med. 1980; 92: 65
  • Fogelman I., Bessent R. G., Citrin D. L., Boyle I. T., Greig W. R. The use of whole body retention of Tc‐99m diphosphonate in the diagnosis of metabolic bone disease. J. Nucl. Med. 1978; 19: 270
  • Fogelman I., Bessent R. G., Cohen N. H., Hart D. M., Lindsay R. Skeletal uptake of diphosphonate: method for prediction of postmenopausal osteoporosis. Lancer 1980; ii: 667
  • Fogelman I., Bessent R. G., Scullion J. E., Cuthbert G. F. A critical evaluation of 24 hour whole body (skeletal) retention of diphosphonate measurements. Radioaktive Isotopen in Klinik and Forschung, R. Hofer, H. Bergmann. Egermann, Vienna 1982
  • Gruson M., Miravet L., Hioco D. The relationship between hydroxyprolinuria, the results of kinetic exploration (Ca45) and the serum alkaline phosphatases. Fourth European Symposium on Calcified Tissues, P. J. Gaillard, A. Van den Hoof, R. Steendijk. Excerpta Medica Foundation, Amsterdam 1966
  • Heaney R. P. A unified concept of osteoporosis. Ann. Intern. Med. 1965; 39: 877
  • Hodgkinson A., Thompson T. Measurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex. J. Clin. Pathol. 1982; 35: 807
  • Hyldstrup L., Mogensen N. B., Jensen G. F., McNair P., Transbøl I. Urinary 99m‐Tc‐diphosphonate excretion as a simple method to quantify bone metabolism. Scand. J. clin. Lab. Invest. 1984; 44: 105
  • Klein L., Lafferty F. W., Curtiss P. H., Jr. Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover. Metabolism 1964; 13: 272
  • Knop J., Montz R., Schneider C., Stritzke P., Dorn‐Quint G., Nordmeyer J. P., Kruse H. P., Kuhlencordt F. Bone calcium exchange in primary hyperparathyroidism as measured by 47Calcium kinetics. Metabolism 1980; 29: 819
  • Lauffenburger T., Olah A. J., Dambacher M. A., Guncaga J., Lentner C., Haas H. G. Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease. Metabolism 1977; 26: 589
  • Martin P., Schoutens A., Manicourt D., Berbmann P., Fuss M., Verbanck M. Whole body and regional retention of 99m‐Tc‐labeled pyrophosphate at 24 hours: Physiological basis of the method for assessing the metabolism of bone in disease. Calcif. Tissue Int. 1983; 35: 37
  • Martin W., Fogelman I., Bessent R. G. Measurements of 24‐hour whole body retention of Tc‐99m HEDP by a gamma camera. J. Nucl. Med. 1981; 22: 542
  • Nordin B. E.C., Heyburn P. J., Horsman A., Aron J., Marshall D., Crilly R. G. Osteoporosis and osteomalacia. Clin. Endocrinol. Metab. 1980; 9: 177
  • Posen S., Cornich C., Kleerekoper M. Alkaline phosphatase and metabolic bone disease. Metabolic Bone Disease, L. V. Avioli, S. M. Krane. Academic Press, New York 1977
  • Riggs B. L., Jowsey J., Kelly P. J., Hoffman D. L., Arnaud C. D. Studies on pathogenesis and treatment in postmenopausal and senile osteoporosis. Clin. Endocrinol. Metab. 1973; 2: 317
  • Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J. Clin. Invest. 1981; 67: 328
  • Stepan J., Pacovsky V., Horn V., Silinkova‐Malkova E., Vokrouhlicka O., Konopasek B., Formankova J., Hrba J., Marek J. Relationship of the activity of the bone isoenzyme of the serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neo‐plastic bone diseases. Eur. J. Clin. Invest. 1978; 8: 373

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.